GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (NAS:OGI) » Definitions » Interest Coverage

OGI (Organigram Global) Interest Coverage : N/A (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Organigram Global Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Organigram Global's Operating Income for the three months ended in Mar. 2025 was $-5.3 Mil. Organigram Global's Interest Expense for the three months ended in Mar. 2025 was $0.0 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Organigram Global's Interest Coverage or its related term are showing as below:


OGI's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.05
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Organigram Global Interest Coverage Historical Data

The historical data trend for Organigram Global's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Organigram Global Interest Coverage Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 - - - N/A

Organigram Global Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A - N/A N/A N/A

Competitive Comparison of Organigram Global's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Organigram Global's Interest Coverage falls into.


;
;

Organigram Global Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Organigram Global's Interest Coverage for the fiscal year that ended in Sep. 2024 is calculated as

Here, for the fiscal year that ended in Sep. 2024, Organigram Global's Interest Expense was $0.0 Mil. Its Operating Income was $-26.3 Mil. And its Long-Term Debt & Capital Lease Obligation was $2.5 Mil.

GuruFocus does not calculate Organigram Global's interest coverage with the available data.

Organigram Global's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Organigram Global's Interest Expense was $0.0 Mil. Its Operating Income was $-5.3 Mil. And its Long-Term Debt & Capital Lease Obligation was $5.7 Mil.

GuruFocus does not calculate Organigram Global's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Organigram Global  (NAS:OGI) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Organigram Global Interest Coverage Related Terms

Thank you for viewing the detailed overview of Organigram Global's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.